Table 1.

Correlation between change from double-blind baseline to Week 12 and Week 60 in Neuro-QoL Short Form Fatigue scores and MG-ADL, QMG and MG-QoL 15r scores

Visit	n	MG-ADL (r, p-value)		QMG (r, p-value)		MG-QoL 15r (r, p-value)
		Pearson’s coefficient	Spearman’s coefficient	Pearson’s coefficient	Spearman’s coefficient	Pearson’s coefficient	Spearman’s coefficient
Baseline	161	0.485, < 0.001	0.462, < 0.001	0.433, < 0.001	0.447, < 0.001	0.771, < 0.001	0.771, < 0.001
Week 12	165	0.733, < 0.001	0.749, < 0.001	0.587, < 0.001	0.589, < 0.001	0.858, < 0.001	0.863, < 0.001
Week 60	92	0.770, < 0.001	0.775, < 0.001	0.609, < 0.001	0.576, < 0.001	0.890, < 0.001	0.897, < 0.001

n represents number of patients with available data for MG-ADL, QMG, MG-QoL 15r and Neuro-QoL Short Form fatigue scores at each time point

MG-ADL Myasthenia Gravis Activities of Daily Living, MG-QoL 15r Myasthenia Gravis Quality of Life 15-item revised, Neuro-QoL Quality of Life in Neurological Disorders, QMG Quantitative Myasthenia Gravis, r correlation coefficient